Weiner, HL: Multiple Sclerosis. In Current Neurology, eds. Tyler, H.R. and Dawson, D.M., Houghton Mifflin, pp. 53–85, 1978.

Fields, B.N., Weiner, H.L., Ramig, R.F., and R. Ahmed: Genetics of reovirus: aspects related to virulence and viral persistence. In Persistent Virus, eds. Stevens and Todaro, Academic Press, pp. 389–398, 1978.

Fields, B.N., Weiner, H.L., Ramig, R.F., Ray, U., Drayna, D.T. and A.H. Sharpe: The role of the reovirus hemagglutinin in viral virulence. In Munich Symposia on Microbiology. Mechanisms of Viral Pathogenesis and Virulence. Eds. P.A. Bachmann, WHO Collaborating Centre for Collection and Evaluation of Data on Comparative Virology, Federal Republic of Germany, pp. 21–33, 1979.

Fields, B.N., Weiner, H.L., Drayna, D.T. and A.H. Sharpe: The role of the reovirus hemagglutinin in viral virulence. New York Academy of Sciences, Genetic Variation of Viruses, November 28–30, 1979 conference proceedings.

Achtman, M., Gibbons, R.J., Gotschlich, E.C., Henning, U., Klenk, H.D., Laufs, R., Overath, P., Richmond, M.H., Simons, K., Swanson, J., and H.L. Weiner: Contact and entry. In The Molecular Basis of Microbial Pathogenicity, eds. H.Smith, J.J., Skehel, and Turner, M.J., pp. 69–86, Dahlem Konferenzen 1980, Weinheim: Verlag Chemie.

Wechsler, S.L., Meissner, H.C., Ray, U.R., Weiner, H.L., Rustigian, R., and B.N. Fields: Immune response in subacute sclerosing panencephalitis and multiple sclerosis: antibody response to measles virus proteins. Proceedings of Negative Strand Viruses meeting, V3: 615– 622, 1981.

Hauser, S.L., Ault, K.A., Bresnan, M.J. and H.L. Weiner: Lymphocyte capping in the muscular dystrophies: A review. In Disorders of the Motor Unit, Schotland, D.L. (ed.), John Wiley and Sons, Inc., pp. 811–820, 1982.

Fields, B.N. and H.L. Weiner: Mechanism of viral injury to the nervous system. In Neuronalglial Cell Interrelationships, T.A. Sears (ed.), New York, SpringerVerlag, pp. 217–228, 1982.

Weiner, H.L., Arnason, B.G.W., Bauer, H.J., Felgenhauer, K.M.A., Fields, B.N., Gerhard, W.U., Hille, B., Johnson, R.T., Mims, C., Ritchie, J.M., Pappenheimer, A.M., Jr., Sears, T.A., Ter Meulen, V., and B. Waksman: Injury. State of the Art Report. In Neuronalglial Cell Interrelationships, T.A. Sears (ed.), New York, SpringerVerlag, pp. 271–286, 1982.

Weiner, H.L. and S.L. Hauser: Neuroimmunology I. Immunoregulation in neurological disease. Ann. Neurol. 11: 437–449, 1982.

Weiner, H.L. and S.L. Hauser: Neuroimmunology II. Antigenic specificity of the nervous system. Ann. Neurol. 12: 449–509, 1982.

Tardieu, M., Epstein, R.L., and H.L. Weiner: Interactions of viruses with cell surface receptors. Int. Rev. Cytol. 80: 27–57, 1982.

Hauser, S.L., Fosburg, M., Kevy, S., and H.L. Weiner: Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis. In Therapeutic Apheresis and Plasma Perfusion, R.S.A. Tindall (ed.), Alan R. Liss, Inc., New York, pp. 239–254, 1982.

Weiner, H.L. and S.L. Hauser: Cellular immunological studies with monoclonal antibodies in Neurological Diseases. In Clinics in Immunology and Allergy, vol. 2, W.B. Saunders Company Ltd., pp. 457–467, June 1982.

Weiner, H.L., and S.L. Hauser: Immunoregulation in multiple sclerosis. Prog. Brain Res. 59: 23–27, 1983.

Weiner, H.L., Tardieu, M., Epstein, R.L., Fontana, A., and M.L. Powers: Viral interactions with receptors in the central nervous system and on lymphocytes. Prog. Brain Res. 59: 23–27, 1983.

Hauser, S.L., and H.L. Weiner: Cellular regulation of the human immune response and its relation to multiple sclerosis. In Neuroimmunology, Behan and Spreafico, eds., Raven Press, New York, pp. 247–260, 1984.

Brown, R.H., Dichter, M.A., and H.L. Weiner: Two immunological approaches to the characterization of neurons. In Recent Progress in Motor Neuron Diseases, F. Clifford Rose (ed.), Progress in Neurology Series, Pitman Press, London, pp. 379–383, 1984.

Brown, R.H. and H.L. Weiner: The relationship between poliovirus and amyotrophic lateral sclerosis. In Recent Progress in Motor Neuron Diseases, F. Clifford Rose (ed.), Progress in Neurology Series, Pitman Press, London, pp. 349–359, 1984.

Weiner, H.L., and S.L. Hauser: Recent advances in neuroimmunology. In Harrison's Principles of Internal Medicine, Update V, Petersdorf, Adams, Braunwald, Isselbacher, Martin, and Wilson (eds.), pp. 251–272, 1984.

Greene, M.I., Weiner, H.L., Dichter, M.A., and B.N. Fields: Syngeneic monoclonal antiidiotypic antibodies identify reovirus type 3 hemagglutinin receptors on immune and neuronal cells. In Monoclonal and Antiidiotypic Antibodies: Probes for Receptor Structure and Function, Ventor, C. (ed.), Alan Liss, Inc., New York, pp. 177–187, 1984.

Weiner, H.L., and D.A. Hafler: Multiple sclerosis. In Current Neurology, Appel, S.H. (Ed.), Yearbook Medical Publishers, pp. 123–151, 1985.

Weiner, H.L., and D.M. Dawson: Multiple sclerosis. In Current Therapy in Allergy, Immunology and Rheumatology, Lichtenstein, L.M. and Fauci, A.S. (eds.), B.C. Decker Inc., Toronto and Philadelphia, pp. 246–248, 1985.

Weiner, H.L., Hauser, S.L., Hafler, D.A., Fallis, R.J., Lehrich, J.R., and D.M. Dawson: The use of cyclophosphamide in the treatment of multiple sclerosis. Ann. N. Y. Acad. Sci. 436: 373–381, 1985.

Weiner, H.L., Hafler, D.A., Fallis, R.J., Johnson, D., Ault, K.A., and S.L. Hauser: Tcell subsets in patients with multiple sclerosis. Ann. N. Y. Acad. Sci. 436: 281–290, 1985.

Levin, L.A., and H.L. Weiner: Antigen presentation by astrocytes—A commentary. J. Mol. Cell. Immunol. 2: 281–282, 1986.

Weiner, H.L., and S. De La Monte: Case records of the Massachusetts General Hospital. A 24year old woman with a threemonth history of progressive mental deterioration. N. Engl. J. Med. 314: 1689, 1986.

Hafler, D.A., and H.L. Weiner: Activated Tcells and antigen reactivity in the cerebrospinal fluid and blood of patients with multiple sclerosis, Belgian Conference on Cerebrospinal Fluid in Multiple Sclerosis. In Cellular and Humoral Immunological Components of Cerebrospinal Fluid in Multiple Sclerosis, Lowenthal, A. and Raus, J., 129: 261–272, 1987.

Lee, S.J., Benjamin, D.S., Weiner, H.L., Seidman, J.G., Duby, A.D., Ang, S., and D.A. Hafler: Clonality and TCell Receptor q Chains in Immune Compartments: Examination of Cerebrospinal Fluid Derived TCell Clones. In The TCell Receptor, Davis, M.M., and Kappler, J., 73: 87–97, 1988.

Weiner, H.L., and D.A. Hafler: Immunotherapy of multiple sclerosis. Ann. Neurol. 23: 211–222, 1988.

Hafler, D.A., and H.L. Weiner: Tcells in multiple sclerosis and inflammatory central nervous system diseases. Immunol. Rev. 100: 307–332, 1988.

Weiner, H.L., and D.A. Hafler: New Strategies for the Immunotherapy of Multiple Sclerosis. in Neuroimmunological Diseases: Recent advances in pathogenesis and treatment. ed. A. Igata. University of Tokyo Press, pp. 117–132, 1988.

Hafler, D.A. and H.L Weiner: Examination of cerebrospinal fluid derived TCell clones. in Neuroimmunological Diseases: Recent advances in pathogenesis and treatment. ed. A. Igata. University of Tokyo Press, pp. 105–116, 1988.

Cohen, I.R. and H.L. Weiner: Tcell vaccination. Immunol. Today 9: 332–336, 1988.

Hafler, D.A. and H.L. Weiner: MS: a CNS and systemic autoimmune disease. Immunol. Today 10: 104–107, 1989.

Johnson, D., Toms, R. and H.L. Weiner: Studies of myelin breakdown in vitro, in Myelination and Demyelination, ed. Seung U. Kim, Plenum Press, New York, 1989.

Hafler, D.A., Brod, S.A., and H.L. Weiner: Immunoregulation in Multiple Sclerosis. Res. Immunol. 140: 233–239, 1989.

Weiner, H.L. and D. Paty: Diagnostic therapeutic trials in multiple sclerosis: A new look. Summary of Jekyll Island workshop. Neurology 39: 972–976, 1989.

Dawson, D.M., Carter, J.L., Hafler, D.A., and H.L. Weiner. Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies. Proceedings: International Symposium on Multiple Sclerosis, Rome, Italy, 1989.

Lussier, M.L., Hafler, D.A., and H.L. Weiner. Multiple sclerosis: Therapeutic overview, in Handbook of Multiple Sclerosis, ed. Cook, S.D., Marcel Dekker, NY, pp. 317–326, 1990.

Khoury, S.J., Weiner, H.L., and D.A. Hafler. Immunologic basis of multiple sclerosis, in Handbook of Multiple Sclerosis, ed. Cook, S.D., Marcel Dekker, NY, pp. 129–149, 1990.

Wucherpfennig, K., and H.L. Weiner. Immunologic mechanisms in chronic demyelinating diseases of the central and peripheral nervous system, in Immunologic mechanisms in neurologic and psychiatric disease, ed. Waksman, B.H., Raven Press, Ltd., NY, pp. 105–116, 1990.

Matsui, M., Hafler, D.A., and H.L. Weiner. Neurologic Aspects of Autoimmunity, in Molecular Autoimmunity, ed. Talal, Academic Press, Ltd., NY, pp. 359–383, 1991.

Wucherpfennig, K.W., Weiner, H.L., and D.A. Hafler: TCell recognition of myelin basic protein. Immunol. Today 12(8), 1991.

Miller, A., Hafler, D.A., and H.L. Weiner: Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases. FASEB J. 5(11): 2560–2566, 1991.

Khoury, S.J., and H.L. Weiner: Therapy of Multiple Sclerosis with particular reference to recent clinical trials. Curr. Opin. Neurol. Neurosurg. 4(2), 1991.

Miller, A., Hafler, D.A., and H.L. Weiner: Immunotherapy in autoimmune diseases. Curr. Opin. Immunol. 3: 936–940, 1991.

Mackin, G.A., Dawson, D.M., Hafler, D.A., and H.L. Weiner: Treatment of multiple sclerosis with cyclophosphamide, in Treatment of Multiple Sclerosis, eds. Rudick, R.A. and D.E. Goodkin, Springer–Verlag, NY, pp. 199–216, 1992.

Hafler, D.A., Brod, S.A., and H.L. Weiner: Experimental approaches to specific immunotherapy in multiple sclerosis, in Treatment of Multiple Sclerosis, eds. Rudick, R.A. and D.E. Goodkin, Springer-Verlag, NY, pp. 301–307, 1992.

Hafler, D.A., Matsui, M., Wucherpfennig, K.W., Ota, K., and H.L. Weiner: The potential of restricted Tcell recognition of myelin basic protein epitopes in the therapy of multiple sclerosis, in Antigen and Clone-Specific Immunoregulation, ed. Edelson, R.L., New York Academy of Sciences, NY, pp. 251–265, 1992.

Weiner, H.L., Zhang, Z.J., Khoury, S.J., Miller, A., Al-Sabbagh, A., Brod, S.A., Lider, O., Higgins, P., Sobel, R., Nussenblatt, R.B., and D.A. Hafler: Antigen-driven peripheral immune tolerance: Suppression of organ-specific autoimmune diseases by oral administration of autoantigens, in Antigen and Clone-Specific Immunoregulation, ed. Edelson, R.L., New York Academy of Sciences, NY, pp. 227–232, 1992.

Weiner, H.L., Miller, A., Khoury, S.J., Zhang, Z.J., Al-Sabbagh, A., Brod, S.A., Lider, O., Higgins, P., Sobel, R., Matsui, M., Sayegh, M., Carpenter, C., Eisenbarth, G., Nussenblatt, R.B., and D.A. Hafler: Suppression of organ-specific autoimmune diseases by oral administration of autoantigens. Proc. of the 8th Intl. Congr. of Immunology, Budapest, 1992.

Zhang, J., Weiner, H.L., and D.A. Hafler: Autoreactive Tcells in multiple sclerosis. Int. Rev. Immunol. 9(3): 183–201, 1992.

Nussenblatt, R.B., de Smet, M.D., Weiner, H.L., and I. Gery: The treatment of the ocular complications of Behçet's disease with oral tolerization, in Behçet's Disease: Proceedings of the 6th International Conference on Behçet's Disease, held in Paris, France, 30th June-1st July 1993, ed. Wechsler, B., and P. Godeau, Elsevier, Amsterdam, 1993.

Friedman, A., Al-Sabbagh, A., Santos, L.M.B., Fishman-Lobell, J., Polanski, M., Prabhu Das, M., Khoury, S.J., and H.L. Weiner: Oral tolerance: a biologically relevant pathway to generate peripheral tolerance against external and self antigens, in Chemical Immunology: Mechanisms of Immune Regulation, ed. Granstein, R.D., Karger, Basel, NY., Vol. 58, pp. 259–290, 1994.

Weiner, H.L., Friedman, A., Miller, A., Khoury, S.J., Al-Sabbagh, A., Santos, L., Sayegh, M., Nussenblatt, R.B., Trentham, D.E., and D.A. Hafler: Oral Tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12: 809–37, 1994.

Sayegh, M.H., Weiner, H.L. and C.B. Carpenter: Oral Tolerance. Pancreatic Islet Transplantation Volume II, ed. Lanza, R.P., and W.L. Chick, R.G. Landes Co., Ch.13, pp. 153–159, 1994.

Al-Sabbagh, A., and H.L. Weiner: Rat experimental autoimmune encephalomyelitis, in Guidebook to Animal Models for Autoimmune Diseases, ed. Yelles, M., and A. Miller, Academic Press, Ltd., NY., Ch.2, pp. 15–22, 1994.

Weiner, H.L. Commentary: Oral tolerance. Proc. Nat. Acad. Sci. USA 91: 10762–10765, 1994.

Weiner, H.L., Hohol, M.J., Khoury, S.J., Dawson, D.M., and D.A. Hafler: Therapy for multiple sclerosis. Neurol. Clin. 13(1): 173–196, 1995.

Weiner, H.L., Miller, A., Khoury, S.J., Zhang, Z.J., al- Sabbagh, A., Brod, S.A., Lider, O., Higgins, P., Sobel, R., and M. Matsui: Treatment of autoimmune diseases by oral tolerance to autoantigens. Adv. Exp. Med. Biol. 371B: 1217–1223, 1995.

Hafler, D.A., and H.L. Weiner: Immunologic mechanisms and therapy in multiple sclerosis. Immunol. Rev. 144: 75–107, 1995.

Weiner, H.L. Oral Tolerance: Immunologic mechanisms and treatment of autoimmune diseases. Essentials of Mucosal Immunology, Ch.39, 555–561, 1996.

Windhagen, A., Nicholson, L.B., Weiner, H.L., Kuchroo, V.K., and D.A. Hafler: Role of Th1 and Th2 Cells in Neurologic Disorders. Th1 and Th2 Cells in Health and Disease ed. Romagnani, S. Karger NY, pp.170–186, 1996.

Olek, M.J., Hohol, M.J., and H.L. Weiner: Methotrxate in the treatment of multiple sclerosis. Ann. Neurol. 39: 684, 1996.

Encinas, J.A., Weiner, H.L., and V.K. Kuchroo: Inheritance of susceptibility to experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45: 1–15, 1996.

Chen, Y.H., and H.L. Weiner: Dose-dependent activation and deletion of antigen-specific Tcells following oral tolerance. Ann. N. Y. Acad. Sci. 778: 111–121, 1996.

Nelson, P.A., Akselband, Y., Dearborn, S.M., Al-Sabbagh, A., Tian, Z.J., Gonnella, P.A., Zamvil, S.S., Chen, Y., and H.L. Weiner: Effect of oral beta interferon on subsequent immune responsiveness. Ann. N. Y. Acad. Sci. 778: 145–155, 1996.

Hohol, M.J., Khoury, S.J., Cook, S.L., Orav, E.J., Hafler, D.A., and H.L. Weiner: Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial. Ann. N. Y. Acad. Sci. 778: 243–250, 1996.

Fukaura, H., Kent, S.C., Pietrusewicz, M.J., Khoury, S.J., Weiner, H.L., and D.A. Hafler: Antigen-specific TGF??1 Secretion with bovine myelin oral tolerization in multiple sclerosis. Ann. N. Y. Acad. Sci. 778: 251–257, 1996.

Nussenblatt, R.B, Whitcup, S.M., de Smet, M.D., Caspi, R.M., Kozhich, A.T., Weiner, H.L., Vistica, B., and I. Gery: Intraocular inflammatory disease (Uveitis) and the use of oral tolerance. Ann. N. Y. Acad. Sci. 778: 325–337, 1996.

Sayegh, M.H., Khoury, S.J., Hancock, W.W., Weiner, H.L., and C.B. Carpenter: Mechanisms of oral tolerance by MHC peptides. Ann. N. Y. Acad. Sci. 778: 338–345, 1996.

Maron, R., Blogg, N.S., Polanski, M., Hancock, W., and H.L. Weiner: Oral tolerance to insulin and the insulin B-chain. Ann. N. Y. Acad. Sci. 778: 346–357, 1996.

Akselband, Y., Hoffer, T.L., Nelson, P.A., Gonnella, P.A., and H.L. Weiner: Local and systemic immune responses in SJL/J mice during prolonged oral myelin basic protein administration. Ann. N. Y. Acad. Sci. 778: 358–392, 1996.

Inobe, J.I., Chen, Y., and H.L. Weiner: In vivo administration of IL4 induces TGF?-producing cells and protects animals from experimental autoimmune encephalomyelitis. Ann. N. Y. Acad. Sci. 778: 390–392, 1996.

Matsui, M., Hafler, D.A., and H.L. Weiner: Pilot study of oral tolerance to keyhole limpet hemocyanin in humans. Ann. N. Y. Acad. Sci. 778: 398–404, 1996.

Mordes, J.P., Schirf, B., Roipko, D., Greiner, D.L., Weiner, H.L., Nelson, P.A., and A.A. Rossini: Oral insulin does not prevent insulin-dependent diabetes mellitus in BB rats. Ann. N. Y. Acad. Sci. 778: 418–421, 1996.

Weiner, H.L., Olek, M.J., Hohol, M.J., Khoury, S.J., Dawson, D.M., and D.A. Hafler: Rational therapy in multiple sclerosis. 17: 275–296, 1996.

Weiner, H.L. “Oral tolerance mechanisms and therapy of autoimmune diseases.” Foundation Merieux. Immune Tolerance 239–250, 1996.

Weiner, H.L. Oral Tolerance. Encyc. Immun. 1996.

Weiner, H.L. Mechanisms of oral tolerance and treatment of autoimmune diseases. Alfred Benzon Symposium 40: HLA and Disease—the Molecular Basis. eds Svejgaard, A., Buus, S., Fugger, L. 423–436, 1997.

Weiner, H.L.: Oral tolerance for the treatment of autoimmune diseases. Annu. Rev. Med. 48: 341–351, 1997.

Weiner, H.L. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18: 335–343, 1997.

Liu, L., Rich, B., Inobe, J.I., Chen, W., and H.L. Weiner: A potential pathway of Th2 development during primary immune response: IL10 pretreated dendritic cells can prime naive CD4+ Tcells to secrete IL4. Adv. Exp. Med. Biol. 417: 375-381, 1997.

Weiner, H.L., Gonnella, P.A., Slavin, A., and R. Maron: Oral tolerance: cytokine milieu in the gut and modulation of tolerance by cytokines. Res. Immunol. 148: 528–532, 1997.

Fowler E, Weiner HL. Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases. Biopolymers. 1997;43(4):323-35. Review.

Zamvil, S.S., Soos, J.M., and H.L. Weiner: Pathogensis and treatment of CNS demyelinating disease. Rev. Neurol. (Paris) 154(8–9): 573–575, 1998.

Khoury, S.J., and H.L. Weiner: Multiple sclerosis: what have we learned from magnetic resonance imaging studies? Arch. Intern. Med. 158: 565–573, 1998.

Weiner, H.L:. A 21 point hypothesis on the etiology and treatment of multiple sclerosis. Can. J. Neurol. Sci. 25: 93–101, 1998.

Slavin, A.J., and H.L. Weiner: Oral tolerance therapy for autoimmunity. J Clin Lig. 21: 218–222, 1998.

Weiner, H.L., and A. Miller: Oral tolerance: immune mechanisms and treatment of multiple sclerosis and other autoimmune diseases. In Zhang, J., Hafler, D., Hohlfeld R., Miller, A. (eds.), Immunotherapy in Neuroimmunologic Diseases. Martin Dunitz, 233–244, 1998.

Liu, L.M., and H.L. Weiner: T-cell response to orally administered antigens and its role in the treatment of autoimmune diseases. Chem. Immunol. 71: 139–160, 1998.

Weiner, H.L., and L. Stazzone: Multiple sclerosis. Conn’s Current Therapy W.B. Saunders, 935–941, 1999.

Weiner, H.L., and Y. Komagata: Oral tolerance and the treatment of rheumatoid arthritis. Springer Semin. Immunopathol. 20: 289–308, 1998.

Kuchroo, V.K. and H.L. Weiner: Antigen driven regulation of experimental autoimmune encephalomyelitis. Res. Immunol. 149(9): 759–771, 1998.

Weiner, H.L.: Oral Tolerenace. In Inflammation: Basic principles and clinical correlates, eds. J.I. Gallin and R. Snyderman, third edition. Lippincott Williams & Wilkins. Philadelphia, pp. 1251-1261, 1999.

Weiner, H.L. Commentary: Oral tolerance with Copolymer 1 for the treatment of multiple sclerosis. PNAS 96:3333-3335, 1999.

Balashov, K. and H.L. Weiner: Multiple Sclerosis: Endocrine and Organ Specific Autoimmunity. George S. Eisenbarth (ed), R.G. Landes. Austin, TX. 195-212, 1999.

Faria, A.M. and H.L. Weiner: Oral Tolerance: Mechanisms and Therapeutic Applications. eds. F.J. Dixon. Academic Press, London, UK, Adv Immunol (73):153-264, 1999.

Garcia, G. and H.L. Weiner: Current Topics in Microbiology and Immunology, Vol. 238 Redirection of Th1 and Th2 Responses. Manipulation of Th responses by oral tolerance. 238:123-145, 1999.

Weiner, H. L. Induction of oral tolerance to the acetylcholine receptor for treatment of myasthenia gravis [comment]. J Clin Invest 104, 1667-1668, 1999.

Weiner, H.L. and van Rees, E.P. Mucosal Tolerance. Immunol Lett 69(1):3-4. 1999.

Karussi, D., Weiner, H.L. and Abramsky, O. Multiple Sclerosis vs. Lyme disease: a case presentation to a discussant and a review of the literature. Mult Scler 5(6): 395-402. 1999.

Komagata, Y. and H. Weiner. “Oral Tolerance.” Reviews in Immunogenetics 2:61-73, 2000.

Weiner, H. L. . Oral tolerance, an active immunologic process mediated by multiple mechanisms. J Clin Invest 106:935-937. 2000.

Weiner, H. L. . Role of Cytokines in Multiple Sclerosis and in Mucosal Tolerance. Cytokines and Autoimmune Disease. 11: 273-293. 2001.

Weiner, H.L. Oral Tolerance: immune mechanisms and the generation of Th3-type TGF-beta secreting regulatory cells. Microbes and Infection 3:947-954. 2001.

Lemere CA, Maron R, Selkoe D, and Weiner, HL. Nasal Vaccination with b-Amyloid peptide for the treatment of Alzheimer’s Disease. DNA and Cell Biology 20:11:705-711. 2001.

Weiner, HL. The mucosal milieu creates tolerogenic dendritic cells and Tr1 and Th2 regulatory cells. Nature Immunology. 2:8,671-672. August 2001.

Weiner, HL. Induction and mechanism of action of transforming growth factor beta secreting Th3 regulatory cells. Immunologic Reviews. 182:208-214.2001.

Maron, R and Weiner HL. Oral Tolerance and Diabetes (Ch 9). Immunologically Mediated Endocrine Diseases. Lippincott Williams & Wilkins. 201-218. 2001.

Weiner, HL. Clinical Applications of Oral Tolerance (Ch 11). Oral Tolerance: The Response of the Intestinal Mucosa to Dietary Antigens. Eureka Press. 2002.

Izikson L, Klein RS, Luster AD, Weiner HL. Targeting Monocyte Recruitment in CNS Autoimmune Disease. (Millenium award recipient contribution). Clinical Immunology. 103:2:125-131.2002.

Makhlouf K, Weiner HL, Khoury S. Potential of B2 adrenoceptor agonists as add on therapy for multiple sclerosis. CNS Drugs. 16:1) 1-8. 2002.

Weiner HL, Selkoe DJ. Inflammation and therapeutic vaccination in CNS diseases. Nature. Dec 19-26;420(6917):879-84 2002.

Monsonego A, Weiner HL. Immunotherapeutic approaches to Alzheimer's disease. Science. 2003 Oct 31;302(5646):834-8.

Wu HY, Weiner HL. Oral tolerance. Immunol Res. 2003;28(3):265-84.

Hommes OR, Weiner HL. Clinical practice of immunosuppressive treatments in multiple sclerosis: results of a second international questionnaire. J Neurol Sci. 2004 Aug 15;223(1):65-7.

Weiner HL. Immunosuppressive treatment in multiple sclerosis. J Neurol Sci. 2004 Aug 15;223(1):1-11.

Weiner HL. Clinical Applications of Oral Tolerance (Ch. 10). Oral Tolerance: The Response of the Intestinal Mucosa to Dietary Antigens. 164-203. Plenum Publishers 2004.

Weiner HL. Multiple Sclerosis is an inflammatory T-Cell-mediated autoimmune disease. Arch Neurol. 2004;61:1613-15.

Meier DS, Weiner HL, Khoury SJ, Guttmann CRG. Magnetic resonance imaging surrogates of multiple sclerosis pathology and their relationship to central nervous system atrophy. J Neuroimaging, Jul 2004; 14: 46S - 53S.

Weiner HL. Immunosuppressive treatment in multiple sclerosis. J Neurol Sci. 2004 Aug 15;223(1):1-11.

Weiner HL. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease.
Arch Neurol. 2004 Oct;61(10):1613-5.

Weiner HL. Current issues in the treatment of human diseases by mucosal tolerance. Ann N Y Acad Sci. 2004 Dec;1029:211-24.

Gauthier SA, Buckle GJ, Weiner HL. Immunosuppressive therapy for multiple sclerosis. Neurol Clin. 2005 Feb;23(1):247-72, viii-ix.

Faria AM, Weiner HL. Oral tolerance. Immunol Rev. 2005 Aug;206:232-59. Review.

Quintana FJ, Weiner HL. Understanding natural and pathological autoimmunity. J Neuroimmunol. 2006 Mar 10; [Epub ahead of print].

Weiner, HL Frenkel D. Immunology and immunotherapy in Alzheimer’s disease. Nature Rev Immunol. 2006 May; 6:404-16. Review.

Gauthier SA, Glanz BI, Mandel M, Weiner HL. A model for the comprehensive investigation of a chronic autoimmune disease: The multiple sclerosis CLIMB Study. J.Auto.Rev. 2006 02.012 533-36.

Quintana FJ, Weiner HL. “Omics” in the study of Multiple Sclerosis (MS). Handbook of Genomic Medicine. Part III, Diseases, Chronic Inflammatory Disease. Academic Press/Elsevier.

Kappos L, Bates D, Hartung HP, Havrdova E, Miller D, Polman CH, Ravnborg M, Hauser SL, Rudick RA, Weiner HL, O'Connor PW, King J, Radue EW, Yousry T, Major EO, Clifford DB. Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurol. 2007 May;6(5):431-41. Review.

Meier DS, Weiner HL, Guttmann CR. Time-series modeling of multiple sclerosis disease activity: a promising window on disease progression and repair potential? Neurotherapeutics. 2007 Jul;4(3):485-98. Review.

Bluestone JA, Thomson AW, Shevach EM, Weiner HL. What does the future hold for cell-based tolerogenic therapy? Nat Rev Immunol. 2007 Aug;7(8):650-4.

Vaknin-Dembinsky A, Weiner HL. Relationship of immunologic abnormalities and disease stage in multiple sclerosis: implications for therapy. J Neurol Sci. 2007 Aug 15;259(1-2):90-4. Epub 2007 May 23. Review.

Weiner HL. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J Neurol. 2008 Mar;255 Suppl 1:3-11.